Evaluation of the STEP Intervention for Long-Term Care Residents Facing Hospital Transfer Decisions

NCT07153341 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-02-06

No results posted yet for this study

Summary

This trial will evaluate whether the Supporting Transitions and Empowering Preferences (STEP) toolkit can improve decision-making about hospital transfers in long-term care residents and their substitute decision-makers and enhance decision self-efficacy in nursing staff.

The trial will answer the questions:

* Does the STEP tool reduce decisional conflict in residents and care partners at the time of transfer decisions?
* Does it improve nurse self-efficacy related to hospital transfer decisions?

Participants will:

* Use the STEP tool during key moments of care planning (admission, care conferences, and acute events)
* Complete a short survey measuring their decisional conflict
* Be supported by trained nurses who use STEP to guide hospital transfer discussions

Researchers will compare data collected before and after the STEP tool is implemented at two long-term care homes to see if it improves shared decision-making related to hospital transfers by reducing decisional conflict.

Conditions

  • LTC-to-hospital Transfer Decision-making

Interventions

BEHAVIORAL

STEP Decision Support Toolkit

The STEP toolkit includes (1) an educational booklet provided upon admission and annually, (2) condition-specific decision aids addressing common clinical scenarios, and (3) structured phone scripts for staff. STEP empowers residents and care partners to actively engage in decision-making, promotes care aligned with personal values, and supports staff in facilitating advance care planning to reduce unnecessary or complex transitions.

Sponsors & Collaborators

  • Bruyère Health Research Institute.

    lead OTHER

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2026-03-04
Completion
2027-09-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07153341 on ClinicalTrials.gov